Letter on ‘Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution’
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 558-559
DOI: 10.1111/apt.70824 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-06-25. Written by Kriti Soni and 1 co-authors. Institution: Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmo…. Cited 1 times so far (Crossref); 10 references. The full text is freely available in PubMed Central.
Abstract (original language)
Povzetek ni na voljo.
Authors and institutions
- Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
- Division of Gastroenterology and Hepatology, MASLD Research Center, University of California San Diego, San Diego, California, USA.
- Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Cite
APA
Soni, K., & Díaz, L. A. (2026). Letter on ‘Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution’. Alimentary Pharmacology & Therapeutics, 64(4), 558-559. https://doi.org/10.1111/apt.70824
Vancouver
Soni K, Díaz LA. Letter on ‘Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution’. Alimentary Pharmacology & Therapeutics. 2026;64(4):558-559. doi:10.1111/apt.70824
BibTeX
@article{Soni2026,
author = {Soni, Kriti and Díaz, Luis Antonio},
title = {Letter on ‘Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution’},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {4},
pages = {558--559},
doi = {10.1111/apt.70824}
}
EUVIMED